Breakthru Medicine Raises $60M in Series A Funding
Breakthru Medicine, a Phoenix‑based oncology startup, announced a $60 million Series A round led by a board of seasoned investors including Dave Morehead, Fred Eshelman and Mark Gergen. The capital will fund expansion of its precision‑therapy platform targeting solid tumors deemed “undruggable.” Breakthru’s pipeline leverages antibody‑drug conjugates, small‑molecule inhibitors and molecular glues, with its first clinical trial projected for early 2027. Founders Steve Potts, Mark Mulvihill and Brian Barnett aim to accelerate development and commercial readiness.
Summit Says FDA Will Decide to Approve Its Cancer Drug by November
Summit Therapeutics announced that the U.S. Food and Drug Administration has set a target date of November 2024 to render a decision on its flagship cancer immunotherapy. The drug, positioned as a next‑generation immuno‑oncology agent, has completed its pivotal Phase III...
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
Biotech is emerging from a multi‑year slump into a new cycle driven by late‑stage, asset‑centric deals, as highlighted at JPM 2026. While headline megadeals were scarce, rumors around Revolution Medicines and Abivax and announced transactions such as Eli Lilly‑Ventyx and GSK‑RAPT underscored...
Type 2 Diabetes and Liver Disease in Tanzania: Insights
A Tanzanian cohort study found that 30% of patients with type 2 diabetes exhibit metabolic dysfunction‑associated steatotic liver disease (MASLD). Obesity, high‑calorie diets and physical inactivity emerged as the strongest predictors, while hypertension and dyslipidemia frequently co‑occurred. The research highlights a...
Is Platelet-to-Neutrophil Ratio Key for Sickle Cell Care?
A recent multicenter study proposes the platelet‑to‑neutrophil ratio (PNR) as a novel biomarker for managing sickle cell disease. Researchers found that patients with elevated PNR experienced more frequent vaso‑occlusive crises and higher hospitalization rates. The ratio, derived from a routine...
Cost Analysis of Obesity Treatment in Iran
Iran’s obesity prevalence has risen to about 25%, driving a sharp increase in treatment demand and costs. Direct medical spending on obesity now exceeds 1% of the national health budget, with bariatric surgery accounting for nearly half of that outlay....
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca announced a $15 billion investment in its China operations through 2030, aimed at bolstering capabilities in cell therapies and radioconjugates. The funding will support the full drug development chain, from design to manufacturing, and expand existing production sites in Wuxi,...
Sanofi Suffers Another Sales Dip For 'Gift to Public Health' Vaccines
Sanofi reported a 2.5% decline in 2025 vaccine revenue to €2 bn, marking a continued sales dip amid rising U.S. vaccine skepticism. The drop was offset by a 31.5% surge in flu and COVID‑19 vaccine sales, driven by higher virus circulation...
Barbados Government and BioMed X Partner to Improve AI-Based Early Diabetic Kidney Disease Modeling
BioMed X, a German pharma innovation hub, has teamed up with the Barbados government and the EU’s PharmaNext programme to launch an AI‑enabled research initiative targeting early diabetic kidney disease in the island’s type‑2 diabetes population. The project will combine...
Sleep Disturbance and Mobile Phone Use: Network Links
A recent study employing network analysis links mobile phone usage patterns to sleep disturbance. The research finds that high-frequency nighttime screen time, especially blue‑light exposure, is the strongest predictor of reduced sleep duration and poorer sleep quality. Young adults and...
Roche Predicts Its Breast Cancer Pill Could Become Its Biggest-Selling Drug
Roche’s oral breast‑cancer therapy is gaining momentum after two positive late‑stage trial readouts demonstrated strong efficacy and tolerable safety. The company has submitted a U.S. FDA filing and expects a decision later this year. An additional pivotal trial will report...
Following Abivax, Formation Bio Licenses miR-124 Drug From China
Formation Bio announced a licensing agreement to acquire rights to a miR‑124‑based drug candidate from a Chinese partner, mirroring the target of French biotech Abivax’s recently successful ulcerative colitis therapy. The deal positions Formation Bio to enter the rapidly expanding...
Sanofi Says Its €15B Dealmaking Budget, R&D Spend Should Help Ease Looming Dupixent Patent Cliff
Sanofi announced a €14‑15 billion budget for mergers and acquisitions in 2026, alongside a bolstered R&D spend of roughly €7 billion. The pharmaceutical giant aims to counter the looming revenue gap from Dupixent’s patent expiration expected around 2027. Management expects the combined...
Lilly Establishes up to $2.7B Repertoire Deal in Second Immune Play of 2026
Eli Lilly has signed a strategic alliance with Repertoire Immune Medicines, providing $85 million upfront and up to $1.84 billion in milestone payments to develop T‑cell‑targeted therapies for autoimmune diseases. The collaboration will use Repertoire’s DECODE platform to pinpoint T‑cell antigen interactions, aiming...
ENA Respiratory Begins Dosing in Phase 2 Study of INNA‑051 Nasal Spray
ENA Respiratory has initiated dosing in a Phase 2 clinical trial of its intranasal antiviral, INNA‑051. The study evaluates the spray’s ability to curb viral replication in the upper respiratory tract of adults presenting mild respiratory symptoms. Approximately 200 participants will...
Otsuka Preps for July Decision on Centanafadine for ADHD
The FDA has placed Otsuka Pharma’s centanafidine under priority review, with a decision expected by July 24. The drug is the first norepinephrine‑dopamine‑serotonin reuptake inhibitor (NDSRI) aimed at children, adolescents, and adults with ADHD, and is backed by four phase 3 trials...
TP53 Mutations Linked to Poor Prognosis in DLBCL
A multi‑center analysis published this week links TP53 mutations to markedly poorer outcomes in diffuse large B‑cell lymphoma (DLBCL). The study, encompassing 1,200 patients treated with R‑CHOP, found TP53 alterations in roughly 20% of cases and associated them with a...
Two Days of Oatmeal Reduce Cholesterol Level
A University of Bonn randomized trial found that a two‑day, calorie‑restricted oatmeal diet lowered LDL cholesterol by about 10% in participants with metabolic syndrome. The intensive oat regimen also produced an average two‑kilogram weight loss and modest blood‑pressure reductions. Gut‑microbiome...
Evolving Views on Hearing Aids and Abandonment
A recent industry study reveals that hearing‑aid abandonment rates have fallen to 15% in the U.S., down from 30% a decade ago, driven by improved device comfort, AI‑powered personalization, and direct‑to‑consumer sales channels. The research highlights that younger adults (35‑54)...
NIR‐Triggered 3D‐Bioprinted Hydrogels for Antibacterial Skin Regeneration
Researchers have developed a near‑infrared (NIR) triggered hydrogel bio‑ink that incorporates up‑conversion nanoparticles (UCNPs) with acrylic acid‑N‑vinyl‑2‑pyrrolidone and carboxymethyl cellulose. The NIR exposure induces rapid hydrogen‑bonding condensation, enabling in‑situ 3D printing of wound‑filling scaffolds. The printed hydrogel generates reactive oxygen...
Bioinspired Ultratough and Rapidly Responsive Hydrogels Empower Silent Communication
Researchers have engineered a starch‑based hydrogel by covalently grafting protocatechuic acid, creating a bioinspired material that is both ultratough and rapidly piezoresistive. The hydrogel’s dynamic hydrogen bonds and π‑π interactions eliminate the typical brittleness‑hysteresis trade‑off, enabling reliable strain‑dependent resistance. Integrated...
AIEgen‐Based Photothermal Nanoparticles With Dual Antibacterial and Anti‐Inflammatory Activities for Enhanced Healing of Infected Diabetic Wounds
Researchers have engineered an aggregation‑induced emission luminogen (AIEgen) that converts near‑infrared light into heat, forming photothermal nanoparticles for diabetic wound therapy. The NIR‑activated particles efficiently kill multidrug‑resistant bacteria such as MRSA and carbapenem‑resistant Pseudomonas, while also disrupting biofilms and mitigating...
Engineered Biomimetic Nanorobots Orchestrate Targeted Nose‐to‐Brain Delivery to Resolve Neuron‐Glia Entanglement Against Parkinson's Disease
Researchers have engineered a biomimetic nanorobot (hPH‑RNPEC) that can be administered intranasally to deliver a combined payload of endogenous miRNAs and curcumin directly to the brain. The platform uses Pueraria lobata‑derived exosomes cloaked in neutrophil‑like membranes, a rabies virus glycoprotein...
Programmable G‐Quadruplex@DNA Nano‐Highway Network Platform Enables One‐Pot Electrochemical Detection of Exosomes for Breast Cancer Lymph Node Metastasis Evaluation
Researchers have created a rapid, one-pot electrochemical sensor for breast‑cancer‑derived exosomes. The device leverages an aptamer‑triggered hybridization chain reaction combined with a streptavidin‑biotin cross‑link to assemble a G‑quadruplex‑DNA nano‑highway network at room temperature. Binding of the vimentin aptamer disassembles the...
Renovating Neural Networks With Viral‐Mediated Gene Transfer From A Tissue Contacting Matrix Mimic
Researchers engineered a self‑assembling peptide hydrogel (Fmoc‑DDIKVAV) to encapsulate adeno‑associated virus delivering brain‑derived neurotrophic factor (AAV‑BDNF). In a mouse Huntington's disease model, the hydrogel‑mediated delivery achieved markedly higher BDNF expression and neuroprotection in the striatum than direct AAV injection. The...
Charge Directed Selective Co‐Assembly of Ionic Complementary Peptide Binary Mixtures
Researchers have shown that designing peptide charge distribution, together with pH, stoichiometry, and concentration, can selectively direct the co‑assembly of ionic complementary peptide binary mixtures. By adjusting these parameters, they control β‑sheet strand alignment, assembly kinetics, nanofiber morphology, and hydrogel...
10 Companies Hiring IT Professionals Now
Biotech firms are aggressively recruiting IT talent as the sector’s digital transformation accelerates. After a mid‑year dip in 2025, job postings rebounded in the last four months and January 2026 listings already surpass December’s total. Ten companies—including AbbVie, Amgen, Lilly...
Tunable Morphological Engineering of Self‐Assembled Copper‐Glutathione Nanoarchitectures: Size‐Dependent Antibacterial Action for Pathogen Infections Management
Researchers have developed size‑tunable copper‑glutathione (Cu‑GSH) nanocapsules using a simple co‑precipitation method, enabling precise control over particle morphology. In kiwifruit trials, the optimized formulation delivered 77% therapeutic and 66% protective efficacy, outperforming conventional copper pesticides. Small spherical nanocapsules penetrated plant...
Ultrasensitive MicroRNA Detection Combining Reduced Graphene Oxide Electrolyte‐Gated Transistors and Machine Learning
Researchers have created an ultrasensitive biosensor that merges DNA‑functionalized reduced graphene oxide (rGO) electrolyte‑gated transistors (EGTs) with machine‑learning analytics to detect cancer‑ and neuro‑related microRNAs. The platform targets the miR‑34 family and achieves a limit of detection as low as...
Sulfur‐Fumigation Engineered Ceria Nanoparticles With Augmented Oxygen Vacancies for Enhanced Therapy of Drug‐Induced Liver Injury
Researchers applied sulfur fumigation to reconfigure ceria nanoparticle surfaces, exposing (200) and (220) crystal facets and generating abundant oxygen vacancies. This structural shift dramatically boosts the particles’ reactive oxygen species (ROS) scavenging capability while maintaining a liver‑targeting hydrodynamic size (~136 nm)....
Tenpoint Gets FDA Nod for Presbyopia Eye Drop and $235M
Tenpoint Therapeutics received FDA approval for its presbyopia eye drop, YUVEZZI, marking the first pharmacologic therapy for age‑related near‑vision loss. A Phase 3 trial demonstrated a statistically significant two‑line improvement in near visual acuity. The company simultaneously announced a $235 million financing...
Bionano Mapping Reveals Complexities of Chromosomal Duplications
Bionano Genomics announced that its latest optical mapping platform has uncovered unprecedented structural complexity within chromosomal duplications, pinpointing breakpoint architecture at kilobase resolution. The study, involving over 200 patient genomes, revealed that many duplications comprise nested inversions, insertions, and micro‑homology...
Postmortem CT Vs. Autopsy: Fracture Detection Compared
A new meta‑analysis in the International Journal of Legal Medicine compares postmortem computed tomography (PMCT) with traditional autopsy for fracture detection across dozens of forensic cases. The study finds PMCT identifies roughly 15% more minor fractures and achieves a 92%...
Engineered Hydrogel Scaffolds Create Stable Microvasculature
Researchers have engineered a hydrogel scaffold that supports the formation of stable, perfusable microvasculature in vitro. By fine‑tuning matrix stiffness and incorporating angiogenic cues, endothelial cells self‑assemble into lumenized networks that persist for weeks. The platform demonstrated consistent blood‑like flow...
Five-Year Study: Analyzing Factors Behind Patient Falls
A comprehensive five‑year, multi‑center study has identified the primary drivers of patient falls in acute care settings. Researchers analyzed over 200,000 admissions, linking fall incidence to age, medication adjustments, staffing patterns, and environmental hazards. The data reveal that patients older...
Brain Organoids Map How Distinct Autism Mutations Converge in Early Development
Researchers used human induced pluripotent stem cell‑derived brain organoids to map the impact of eight autism‑linked genetic mutations. RNA‑seq across four developmental stages showed that early distinct molecular signatures gradually converge on shared pathways governing neuronal maturation and synapse formation....
Tumour Macrophage States Linked to Unique lncRNAs in Lung Cancer
A new study in *Genes & Immunity* maps long non‑coding RNAs (lncRNAs) that define tumor‑associated macrophage (TAM) states in lung cancer, revealing stark differences between murine and human TAM transcriptomes. The researchers found only a handful of conserved lncRNAs, with...
How IFN Signaling Tunes Macrophage Mitochondria in Inflammation Resolution
A preclinical study at Spain’s CNIC revealed that type‑I interferon (IFN‑I) reprograms macrophage mitochondria through the ISG15 protein. IFN‑I binding to IFNAR lowers mitochondrial membrane potential while paradoxically increasing ATP output, prompting mitochondrial fission. These metabolic shifts boost efferocytosis, accelerating...
2026 Catalysts: The Rise of RNAi
RNA‑interference (RNAi) therapies are moving from experimental to mainstream, with dozens of antisense and siRNA programs slated for pivotal data releases and regulatory decisions in 2026. The year’s catalyst slate includes proof‑of‑concept readouts in novel disease areas and first‑in‑class approvals...
Changes in Cardiff’s C-Suite Amid Late-Stage Push for Cancer Candidate
Cardiff Oncology announced a reshuffle of its senior leadership as it accelerates a late‑stage oncology candidate toward market. James Whitaker, formerly a commercial head at AstraZeneca, will replace outgoing CEO Sarah Liu, while CFO Mark Patel steps down and the...
PredIG: A Clear Predictor for T-Cell Epitope Immunogenicity
Researchers introduced PredIG, an interpretable machine‑learning platform that predicts T‑cell epitope immunogenicity with higher accuracy than existing tools. The model integrates peptide sequence, structural conformation, and immune‑environment context, and was validated across multiple independent cohorts. By revealing the biological drivers...
How Prenatal Viral Infections Shape Immunity
Recent research reveals that viral infections during pregnancy can rewire the developing immune system of the fetus, leading to lasting changes in immune cell composition and function. Studies show that the timing and type of maternal infection dictate whether offspring...
China’s Orphan Drug Exclusivity Could Bolster Market, Incentivize Development
Effective May 15, China will grant orphan drugs a seven‑year market exclusivity and provide a two‑year exclusivity period for pediatric indications. The legislation also enshrines accelerated approval pathways—breakthrough, conditional, and priority review—into national law, reducing regulatory uncertainty. While many implementation details...
Biomimetic Vesicles Engineered From Modified Tumour Cells Act as Personalized Vaccines for Post-Surgical Cancer Immunotherapy
Researchers engineered tumor cells to overexpress STX11, converting them into dendritic‑cell‑like antigen‑presenting units. Membrane fragments from these cells were fused with PLGA nanoparticles carrying a TLR7 agonist, creating RP@SMs vesicles that act as personalized post‑surgical cancer vaccines. The platform demonstrated...
Pediatric Pseudotumor Cerebri: Apelin Isoforms and Oxidative Stress
Researchers published the first molecular profiling of pediatric pseudotumor cerebri, revealing altered apelin isoform levels and heightened oxidative stress in affected children. By comparing cerebrospinal fluid and serum samples to healthy controls, the study linked these biochemical changes to symptom...
ChenMed CEO Warns Against GLP-1s for Seniors
ChenMed chief executive Chris Chen announced that the senior‑focused primary‑care network will stop encouraging the use of GLP‑1 drugs such as Ozempic and Wegovy for weight‑loss purposes. The decision follows internal data linking these medications to higher rates of dehydration,...
Health Expenditure Trends in Mainland China: 2012-2020
China’s total health expenditure rose sharply from roughly 5.2% of GDP in 2012 to 7.1% in 2020, marking a compound annual growth rate of about 6.5%. Government spending accounted for nearly half of the increase, while private out‑of‑pocket payments fell...
Biodegradable Graphene Sensors Made From Agripapers
Researchers at XYZ University have unveiled a new class of biodegradable sensors that combine graphene with agripaper—a paper made from agricultural residues. The devices demonstrate up to 95% of the sensitivity of conventional graphene sensors while fully decomposing in compost...
Sperm DNA Fragmentation: Impact on Mammalian Reproduction
Recent studies reveal that sperm DNA fragmentation (SDF) significantly impairs mammalian reproductive outcomes, lowering fertilization rates and embryo quality. Researchers attribute elevated SDF to oxidative stress, environmental toxins, and advancing male age, prompting a surge in diagnostic testing. Clinical trials...
Round Three of IRA Negotiations Is Expected to Be ‘Manageable’ for Pharma
Analysts say the third round of Medicare drug‑price negotiations under the Inflation Reduction Act will be largely manageable for large pharmaceutical firms. The round focuses on a limited set of high‑cost specialty medicines, with negotiations slated to begin in 2025....
